EGFR and lipoprotein glomerulopathy: This observation, together with the absence of a significant disproportionality signal for renal diseases, such as glomerulopathy or tubule-interstitial diseases suggest that the most common mechanism of renal failure or acute kidney injury related to anti-EGFR therapies is functional, secondary to dehydration which can be due to a digestive toxicity of these drugs.